7/26/2019 STUDI KASUS Farmakoterapi1

1/13

STUDI KASUS 1CHLAMYDIOSIS

Rafka Khoir, Theodora Novenna, Moch.Dik!, Novi An

"#1$%&

7/26/2019 STUDI KASUS Farmakoterapi1

2/13

KASUS

K'cin( ')'r * +'an +era- +adak( den(an (e/aa ke)erahan 'nia-era, +e+era0a hari ke))en/adi +ia-era, keo0ak )eeka- den(an adan!a dic0'r'en- !an( diik'-i che)oi, rhdan (oi-i.

7/26/2019 STUDI KASUS Farmakoterapi1

3/13

Dia(noa

2e/aa dari 0en!aki- -ere+'- ke)erahan )a-a 'nia-era, +e+era0ke)'dian )en/adi +ia-era, keo0ak)eeka- den(an adan!a dichar(e 0

!an( diik'-i che)oi, rhini-i, dan (3en!aki- den(an (e/aa -ere+'-, Cha)!dioi !an( die+a+kan oeh Cha)!dia.

7/26/2019 STUDI KASUS Farmakoterapi1

4/13

Di4erenia dia(noa dari Cha)!dioi 0ada k'cin( a5eine vira rhino-rachei-i, in5ek5eine caicivir', 5eine reovira+ronchia 0ne')onia

7/26/2019 STUDI KASUS Farmakoterapi1

5/13

3en(o+a-an !an( ka)i ak'kan adaah den(an 0an-i+io-ik -e-rac'cine +aik ecara i-e)ik -o0ikan, 0e)+erian o+a- -e-e a-ro0in '5a-0enahan raa aki-, dan 0e)+erian vi-a)in & 'n-'k )e)0erce0a- 0roe 0en!e)+'han.0en(o+a-an diak'kan ea)a * )in(('. Seao+a-, 0enan(anan non%dr'( /'(a 0er' di0erha-iden(an )en/a(a ke+erihan dieki-ar r'an( ra-ere+'-, 0e)+erihan dichar(e 0'r'endike'rkan oeh k'cin(.

7/26/2019 STUDI KASUS Farmakoterapi1

6/13

Te-rac!cine67cac!

Farmakokinetik : Se-eah dia+or0i, o+a- akan die+ar ke e'r'h -'+'h -er)a'k CS8 daa) ka-erei)inai )ea'i f-rai (o)er'ar 0ada (in/a

Farmakodinamik : &eker/a den(an cara )en(ika- ri%+oo) '+'ni- $#S ehin((a in%-ei 0ro-ein

Efek Obat : &ak-erio-a-i

Sa5e-!

Efek Samping : 3e)+erian 0ada hean )'da akan )en!e%+a+kan 0er'%+ahan arna 0ada -'an

Interaksi Obat : Ovaen-:Trivaen- Ka-ion da0a- )en'r'nkan a+%or0i -e-rac!%cine

S'i-a+ii-!Indikasi : Un-'k 0en(o%+a-an in5eki +ak-eri -er'-a)a )!co0a)a, ricke--ia dan cha)!dia

Kontraindikasi : Ha-i%ha-i 0en(%('naan -erhada0 hean )'da, 0enderi-a (an(%('an (in/a dan he

Co- ; R0. ## e-ia0 ka0'

7/26/2019 STUDI KASUS Farmakoterapi1

7/13

Vitamin B-Kompleks (B-COM)

&en-'k ediaan ; er+'k.

Kand'n(an ; i-a)in &1, vi- &", vi- &B, vi- &&$, dan vi- &

Indikai ; 'n-'k )e)+an-' )en('ran(i defvi-a)in, )e)0erk'a- da!a -ahan -'+'h, da)e)0erce0a- 0roe 0en!e)+'han.

Doi ; 1( 'n-'k 1%"L air )in')

7/26/2019 STUDI KASUS Farmakoterapi1

8/13

Rencana 3en(o+a-an Hin((a Se

7/26/2019 STUDI KASUS Farmakoterapi1

9/13

Rencana Non%dr'( Hin((a Se)

7/26/2019 STUDI KASUS Farmakoterapi1

10/13

Ko)'nikai 3en!aki-

7/26/2019 STUDI KASUS Farmakoterapi1

11/13

Advice

7/26/2019 STUDI KASUS Farmakoterapi1

12/13

Sekian, a0akah ada -a)+ahan

7/26/2019 STUDI KASUS Farmakoterapi1

13/13

Teri)akaih, +%-i